HomeCompareSABRP vs MRK

SABRP vs MRK: Dividend Comparison 2026

SABRP yields 9.10% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $35.5K in total portfolio value
10 years
SABRP
SABRP
● Live price
9.10%
Share price
$71.42
Annual div
$6.50
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.3K
Annual income
$0.96
Full SABRP calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SABRP vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSABRPMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SABRP + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SABRP pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SABRP
Annual income on $10K today (after 15% tax)
$773.59/yr
After 10yr DRIP, annual income (after tax)
$0.82/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,327.59/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SABRP + MRK for your $10,000?

SABRP: 50%MRK: 50%
100% MRK50/50100% SABRP
Portfolio after 10yr
$39.0K
Annual income
$4,899.55/yr
Blended yield
12.55%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SABRP
Analyst Ratings
5
Buy
5
Hold
4
Sell
Consensus: Buy
Altman Z
2.3
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SABRP buys
0
MRK buys
0
No recent congressional trades found for SABRP or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSABRPMRK
Forward yield9.10%2.76%
Annual dividend / share$6.50$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$21.3K$56.8K
Annual income after 10y$0.96$9,798.13
Total dividends collected$935.00$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: SABRP vs MRK ($10,000, DRIP)

YearSABRP PortfolioSABRP Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,155$455.05$11,206$366.19$51.00MRK
2$12,173$237.20$12,650$502.35$477.00MRK
3$13,146$120.96$14,407$694.19$1.3KMRK
4$14,127$61.04$16,585$967.82$2.5KMRK
5$15,147$30.65$19,342$1,363.89$4.2KMRK
6$16,223$15.36$22,913$1,947.19$6.7KMRK
7$17,366$7.69$27,662$2,823.89$10.3KMRK
8$18,585$3.84$34,159$4,173.35$15.6KMRK
9$19,888$1.92$43,337$6,308.80$23.4KMRK
10$21,281$0.96$56,776$9,798.13$35.5KMRK

SABRP vs MRK: Complete Analysis 2026

SABRPStock

Sabre Corporation, through its subsidiary, Sabre Holdings Corporation, provides software and technology solutions for the travel industry worldwide. It operates in two segments, Travel Solutions and Hospitality Solutions. The Travel Solutions segment operates as a business-to-business travel marketplace that offers travel content, such as inventory, prices, and availability from a range of travel suppliers, including airlines, hotels, car rental brands, rail carriers, cruise lines, and tour operators with a network of travel buyers comprising online and offline travel agencies, travel management companies, and corporate travel departments. This segment also provides a portfolio of software technology products and solutions through software-as-a-service (SaaS) and hosted delivery models to airlines and other travel suppliers. Its products include reservation systems for carriers, commercial and operations products, agency solutions, and data-driven intelligence solutions. The Hospitality Solutions segment provides software and solutions to hoteliers through SaaS and hosted delivery models. Sabre Corporation was incorporated in 2006 and is headquartered in Southlake, Texas.

Full SABRP Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SABRP vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SABRP vs SCHDSABRP vs JEPISABRP vs OSABRP vs KOSABRP vs MAINSABRP vs JNJSABRP vs ABBVSABRP vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.